Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives
Tullio Golia D’Augè, Andrea Giannini, Giorgio Bogani, et al.
Clinical and Experimental Obstetrics & Gynecology (2023) Vol. 50, Iss. 8
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Approaches to prevention of gynecological malignancies
Federico Ferrari, Andrea Giannini
BMC Women s Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 53
The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer
Noemi Tonti, Tullio Golia D’Augè, Ilaria Cuccu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11239-11239
Open Access | Times Cited: 8
Recent advances in photodynamic therapy combined with chemotherapy for cervical cancer: a systematic review
Lucimara Rodrigues Carobeli, Ana Beatriz Camillo Santos, Laura Beatriz Marques Martins, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 5, pp. 263-282
Closed Access | Times Cited: 8
A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers
Gökçe Şeker Karatoprak, Berrak Altınsoy, Engin Celep, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Comparative cost-effectiveness of first-line pembrolizumab plus chemotherapy vs. chemotherapy alone in persistent, recurrent, or metastatic cervical cancer
Yingtao Lin, Chang Wang, Xiaoyan He, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
The role of liquid biopsy in epithelial ovarian cancer: State of the art
Luigi Della Corte, Gianluca Russo, Francesco Pepe, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104263-104263
Closed Access | Times Cited: 6
Efficacy and safety of BVAC-C in HPV type 16- or 18–positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study
Chel Hun Choi, Jeong‐Won Lee, Duk‐Soo Bae, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Whole-Genome Methylation Sequencing Analysis and Functional Verification of LIM-Homeobox Family Genes in Cervical Cancer
Rong Yu, Qin Yu, Jie Shi, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 87-102
Open Access
Search for Healthcare and Breast/Gynecological Cancer Prevention Among Brazilian Lesbian Cisgender Women
Carolina de Souza, Manoel Antônio dos Santos
Cancer Investigation (2025), pp. 1-12
Closed Access
Factors affecting cervical cancer screening and human papilloma virus vaccination among Middle Eastern refugee women in Türkiye: indicators for social workers and nurses
Yaser Snoubar, Baraka Abusafia, Zekiye Turan
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Interference with CHD1L inhibits the malignant progression and enhances cisplatin sensitivity of ovarian cancer cells by binding PLK1
Kun Qiao, Yuanxiazi Guan, Wenjing Xing
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
Advances in the Prevention of Cervical Cancer by Anti‐Human Papillomavirus Agents
Hangdi Chen, Kai Guo, Zhihao Bai, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
miR-627-5p inhibits malignant progression of cervical cancer by targeting ANGPTL4
Xinghua Wu, Kai Lin, Chen Gao, et al.
European Journal of Histochemistry (2025) Vol. 69, Iss. 2
Open Access
Factors influencing same-day discharge after minimally invasive hysterectomy for malignant and non-malignant gynecological diseases: a systematic review and meta-analysis
Jia Liu, Yali Chen, Xin Tan, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 3
Research progress in intratumoral heterogeneity and clinical significance of ovarian cancer
Tengda Pu, Chengyuan Zhang, Bingfeng Su, et al.
Medicine (2024) Vol. 103, Iss. 4, pp. e36074-e36074
Open Access | Times Cited: 3
Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study
Peng Chen, Xiaolin Li, Wenjie Tang, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111578-111578
Open Access | Times Cited: 3
Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial
Yin Wang, Jing Zhao, Haixi Liang, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102274-102274
Open Access | Times Cited: 7
Leiomyoma and the importance of genetic variation on genes related to the vasculature system - CβS, MTHFR, NOS3, CYBA, and ACE1
Ângela Inácio, Laura Aguiar, Beatriz Deoti e Silva Rodrigues, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2024) Vol. 294, pp. 65-70
Closed Access | Times Cited: 2
Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials
Danxue Huang, Liyuan Ke, Hongxia Cui, et al.
BMC Women s Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Safety and efficacy of Rucaparib in the treatment of ovarian cancer and patients with BRCA mutation: a systematic review and meta-analysis of phase III randomized clinical trials
Mus’ab Theeb Mustafa, Aws Khalid Abushanab, Mahmoud Taysir Mousa, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 1-2, pp. 71-79
Closed Access | Times Cited: 2
Risk factors for venous thromboembolism following knee arthroscopy: A systematic review and meta-analysis of observational studies
Yue Zou, Guodong Zhang, Xiujiang Sun
Heliyon (2024) Vol. 10, Iss. 4, pp. e25939-e25939
Open Access | Times Cited: 2
Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer
Nicolò Bizzarri, Camilla Fedele, Elena Teodorico, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 4, pp. 108250-108250
Open Access | Times Cited: 2
Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer
Gengwei Huo, Ying Song, Peng Chen
Journal of Gynecologic Oncology (2024) Vol. 35, Iss. 5
Open Access | Times Cited: 2
Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma
Ling Yang, Ying Cai, Yunjia Wang, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 2
Response of Bangladesh to the World Health Organization call to eliminate cervical cancer as a public health issue: An observational report
Sejuti Reza, Syed Masudur Rahman Dewan, Mohammad Safiqul Islam, et al.
Health Science Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top